| 3/14/2024 | 300215000000 | IMMUNITY PRODUCTS DOSED OR PACKAGED/PREPARED FOR RETAIL SALE (THEY ARE NOT ONE OF THE MEDICAL DIAGNOSTIC KITS WITHIN THE SCOPE OF MEDICAL DIAGNOSTIC DEVICES. THEY ARE FOR RESEARCH PURPOSES IN THE GENERAL LABORATORY AND ARE NOT PERFORMED IN 2024/16 AND 202 | 2 | UNIT | 127 | N/A | BECKMAN COULTER BİYOMEDİKAL ÜRÜNLER SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/6/2024 | 300241902019 | VACCINE (LABELLED CARTON OF IO102 0,255 MG LYOPHILISED POWDER IN VIAL FOR PROTOCOL IOB_KN-D18 (ROW 2)) (+ FOR USE IN CLINICAL RESEARCH) | 60 | SET | 1244 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/22/2024 | 300215000000 | LABELLED 1X TAK 573 10 MG/ML 50 MG FOR CLINICAL RESEARCH PURPOSES (NOT IN THE SCOPE OF 2024/16 -19 NOTIFICATION.) | 5 | UNIT | 367 | N/A | ŞULE MENE SAĞLIK ARAŞTIRMA EĞİTİM DANIŞMANLIK BİLİŞİM SANAYİ TİCARET ANONİM ŞİRKETİ |
| 3/8/2024 | 300241902019 | VACCINE (MENVEO POWDER AND SOLUTION FOR INJECTION 1 VIAL OF LIOFILIZED POWDER +1 VIAL OF SOLUTION) (TO BE USED IN CLINICAL + HR RESEARCH) | 30 | SET | 2553 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/6/2024 | 300241902019 | VACCINE (LABELLED CARTON OF IO103 0,255 MG LYOPHILISED POWDER IN VIAL FOR PROTOCOL IOB_KN-D18 (ROW 2)) (+ FOR USE IN CLINICAL RESEARCH) | 60 | SET | 1273 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/20/2024 | 300215000000 | IMMUNITY PRODUCT (LABELED 1X CARTON CONTAINING SACITUZUMAB GOVITECAN LYOPHILIZED POWDER FOR SOLUTION+ FOR INFUSION 200 MG VIAL) (TO BE USED IN CLINICAL RESEARCH) | 225 | SET | 67619 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/5/2024 | 300490000000 | MEDICINE (LABELLED COMMERCIAL CARTON CONTAINING IPILIMUMAB 5MG/ML CONCENTRATE 10ML IN VIAL FOR PROTOCOL +D7988C00001) (TO BE USED IN CLINICAL RESEARCH) | 32 | SET | 200751 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/5/2024 | 300215000000 | IMMUNITY PRODUCT (LABELLED CARTON CONTAINING 16 VIALS OF SACITUZUMAB GOVITECAN (IMMU 132) LYOPHILIZE+D 200 MG/50ML) (TO BE USED IN CLINICAL RESEARCH) | 50 | SET | 237208 | N/A | SMO TU LOJİSTİK VE AMBALAJ SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
| 3/20/2024 | 300259000000 | LABORATORY RESEARCH MATERIAL 220518/ | 400 | UNIT | 495 | N/A | BECTON DİCKİNSON İTHALAT İHRACAT LİMİTED ŞİRKETİ |
| 3/12/2024 | 300215000000 | LABELLED SACTUZUMAB 200 MG POWDER'S MATERIAL IS FOR CLINICAL RESEARCH PURPOSES. IT IS NOT IN THE SCOPE OF 2024/16-19 NOTIFICATION. | 1000 | UNIT | 290309 | N/A | MERCK SHARP DOHME İLAÇLARI LİMİTED ŞİRKETİ |